Koers Cannara Biotech Inc. Canadian Securities Exchange
Aandelen
LOVE
CA13765U1012
Gezondheidszorgvoorzieningen & -diensten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CAD | -.--% | -.--% | +87,50% |
Omzet 2022 | 35,84 mln. 26,2 mln. 24,52 mln. | Omzet 2023 | 57,26 mln. 41,86 mln. 39,17 mln. | Marktkapitalisatie | 90,41 mln. 66,09 mln. 61,85 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 2 mln. 1,46 mln. 1,37 mln. | Nettowinst (verlies) 2023 | 6 mln. 4,39 mln. 4,1 mln. | EV/omzet 2022 | 4,32 x |
Nettoschuld 2022 | 36,28 mln. 26,52 mln. 24,82 mln. | Nettoschuld 2023 | 41,51 mln. 30,35 mln. 28,4 mln. | EV/omzet 2023 | 2,3 x |
K/w-verhouding 2022 |
135
x | K/w-verhouding 2023 |
12,9
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 50,58% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 31-12-18 |
Nicholas Sosiak
DFI | Director of Finance/CFO | - | 01-04-19 |
Avi Krivorot
CTO | Chief Tech/Sci/R&D Officer | - | 01-04-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jacob M. Kay
BRD | Director/Board Member | 83 | 25-05-19 |
Donald Olds
BRD | Director/Board Member | 64 | 10-11-20 |
Zohar Krivorot
CEO | Chief Executive Officer | 48 | 31-12-18 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,96% | 272 mln. | |
+33,74% | 261 mln. | |
+49,42% | 194 mln. | |
+44,98% | 131 mln. | |
-42,17% | 119 mln. | |
-28,57% | 121 mln. | |
+115,91% | 119 mln. | |
0,00% | 86,82 mln. | |
+150,00% | 75,33 mln. |
- Beurs
- Aandelen
- Koers LOVE
- Koers LOVE